Long-Acting Injectable Antiretroviral Therapy in Medicare-Enrolled Adults With HIV - Report - MDSpire

Long-Acting Injectable Antiretroviral Therapy in Medicare-Enrolled Adults With HIV

  • By

  • Jose F. Figueroa

  • Rebekah I. Stein

  • Jessica Phelan

  • E. John Orav

  • Grace Luu

  • Shibani S. Mukerji

  • Emily P. Hyle

  • June 12, 2026

  • 0 min

Share

Clinical Report: Injectable Long-Lasting Antiretroviral Therapy for HIV Patients Enrolled in Medicare

Overview

{'add': 'Clarify the year 2023 in the adoption rate statement.'}

Background

{'add': 'Include examples of barriers to access.'}

Data Highlights

{'add': 'Provide significance of the data.'}

Key Findings

{'edit': "Define 'PWH' upon first use."}

Clinical Implications

{'add': 'Suggest specific interventions.'}

Conclusion

{'edit': 'Strengthen the emphasis on addressing disparities.'}

Related Resources & Content

  1. Open Forum Infectious Diseases, 2023 -- Initial Insights on the Use and Efficacy of Long-Acting Injectable Cabotegravir and Rilpivirine at an HIV Clinic in South Side Chicago
  2. Open Forum Infectious Diseases, 2023 -- Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 Years
  3. Open Forum Infectious Diseases, 2023 -- Case Study and Literature Review on the Use of Dual Long-Acting Cabotegravir/Rilpivirine with Lenacapavir in Patients with Integrase Strand Transfer Inhibitor Resistance
  4. Open Forum Infectious Diseases, 2023 -- Implementation of Long-Acting Injectable Antiretrovirals for HIV Prevention and Treatment: Factors Influencing Early Adoption
  5. NIH -- Optimizing Antiretroviral Therapy in the Setting of Viral Suppression
  6. Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges
  7. Optimizing Antiretroviral Therapy in the Setting of Viral Suppression | NIH

Original Source(s)

Long-Acting Injectable Antiretroviral Therapy in Medicare-Enrolled Adults With HIV

  • by Jose F. Figueroa, Rebekah I. Stein, Jessica Phelan, E. John Orav, Grace Luu, Shibani S. Mukerji, Emily P. Hyle

  • June 12, 2026

Related Content

SARS-CoV-2-host and interactions: the dual roles of E3 ubiquitin ligases and ubiquitin-like modification mechanisms in viral infection

Infantile pulmonary abscess due to Mycobacterium abscessus subsp. massiliense identified by integrated mNGS and targeted NGS: a rare case report

Hospital Environment–Associated Sources of Mycobacterium abscessus Infection in Transplant Recipients